Development of tamoxifen (TAM)-resistant breast cancer and the changing role of oestradiol (E2) in the life and death of ER-positive cancer cells

The development of tamoxifen (TAM)-resistant breast cancer and the changing role of oestradiol (E2) in the life and death of ER-positive cancer cells. (A) E2-stimulated growth is inhibited by the use of an aromatase inhibitor to block oestrogen synthesis or TAM to block the ER and prevent oestrogen-stimulated gene transcription. Optimal antioestrogenic effects occur in the absence of pre-existing cell surface signalling mechanisms. (B) Prolonged use of TAM promotes an increase in HER2/neu cell surface signalling that creates a survival pathway phosphorylating the TAM ER complex and coactivator proteins. The transcription complex becomes activated to enhance gene activation and TAM-stimulated growth. If this is Phase I resistance, then oestrogen will also promote growth; so an aromatase inhibitor is an appropriate second-line therapy. If it is Phase II resistance, E2 causes apoptosis. (C) In Phase II tamoxifen resistance, the E2 ER complex collapses the survival mechanisms by dramatically reducing the level of cell surface signalling by preventing HER2/neu mRNA transcription and the nuclear level of NFκB, a transcription factor. (D) In Phase II tamoxifen resistance, the E2 ER complex also enhances the synthesis of Fas receptor mRNA and protein which, in the presence of Fas ligand (FasL) activates caspase 8 and a cascade of events resulting in apoptosis. These figures are summaries of the mechanisms described in and .
Development of tamoxifen (TAM)-resistant breast cancer and the changing role of oestradiol (E2) in the life and death of ER-positive cancer cells

Publication

Targeting oestrogen to kill the cancer but not the patient. (2004) J S Lewis, et al. Br J Cancer. 2004 Mar 8;90(5):944-949. Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Drosophila melanogaster Invertebrates EB EB ncbigene_symbol eb 248478
Drosophila melanogaster Invertebrates EGFR EGFR ncbigene_symbol Egfr 37455
Drosophila melanogaster Invertebrates HER2/neu NEU ncbigene_synonym Nrt 39873
Drosophila melanogaster Invertebrates HER2/neu NEU ncbigene_synonym neur 41085
Drosophila melanogaster Invertebrates TAM TAM ncbigene_synonym PolG1 34792
Drosophila melanogaster Invertebrates TAM TAM ncbigene_synonym pyd 41062
Drosophila melanogaster Invertebrates cycle CYCLE ncbigene_synonym CycE 34924
Drosophila melanogaster Invertebrates cycle CYCLE ncbigene_synonym cyc 40162
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym Fas2 31364
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym FASN1 33524
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym Fas3 35097
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym fand 36514
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym tei 36521
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym rg 44531
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym FASN2 117361
Drosophila melanogaster Invertebrates Fas FAS ncbigene_synonym FASN3 3355111
Drosophila melanogaster Invertebrates FADD FADD ncbigene_symbol Fadd 42594
Drosophila melanogaster Invertebrates NFKB NFKB ncbigene_synonym Dif 35045
Drosophila melanogaster Invertebrates NFKB NFKB ncbigene_synonym dl 35047
Drosophila melanogaster Invertebrates NFKB NFKB ncbigene_synonym Rel 41087
Drosophila melanogaster Invertebrates stops STOPS ncbigene_symbol stops 43683
Homo sapiens Primates EGFR EGFR ncbigene_symbol EGFR 1956
Homo sapiens Primates HER2 HER2 ncbigene_synonym ERBB2 2064
Homo sapiens Primates neu NEU ncbigene_synonym NEU1 4758
Homo sapiens Primates neu NEU ncbigene_synonym NEURL1 9148
Homo sapiens Primates tks TKS ncbigene_synonym CDC42 998
Homo sapiens Primates TAM TAM ncbigene_symbol TAM 8205
Homo sapiens Primates TAM TAM ncbigene_synonym STIM1 6786
Homo sapiens Primates FasL FASL ncbigene_synonym FASLG 356
Homo sapiens Primates Fas FAS ncbigene_symbol FAS 355
Homo sapiens Primates Fas FAS ncbigene_synonym FASN 2194
Homo sapiens Primates FADD FADD ncbigene_symbol FADD 8772
Homo sapiens Primates Caspase CASPASE famplex_relations CASP1 834
Homo sapiens Primates Caspase CASPASE famplex_relations CASP2 835
Homo sapiens Primates Caspase CASPASE famplex_relations CASP4 837
Homo sapiens Primates Caspase CASPASE famplex_relations CASP5 838
Homo sapiens Primates Caspase CASPASE famplex_relations CASP6 839
Homo sapiens Primates Caspase CASPASE famplex_relations CASP8 841
Homo sapiens Primates Caspase CASPASE famplex_relations CASP9 842
Homo sapiens Primates Caspase CASPASE famplex_relations CASP10 843
Homo sapiens Primates Caspase CASPASE famplex_relations CASP12 100506742
Homo sapiens Primates Caspase CASPASE famplex_relations CASP14 23581
Homo sapiens Primates Caspase CASPASE famplex_relations CASP3 836
Homo sapiens Primates Caspase CASPASE famplex_relations CASP7 840
Homo sapiens Primates NFKB NFKB ncbigene_synonym NFKB1 4790
Homo sapiens Primates NFKB NFKB famplex_relations RELA 5970
Homo sapiens Primates NFKB NFKB famplex_relations RELB 5971
Homo sapiens Primates NFKB NFKB famplex_relations REL 5966
Homo sapiens Primates NFKB NFKB famplex_relations NFKB2 4791
Homo sapiens Primates stops STOP ncbigene_synonym MAP6 4135

Chemical mentions

Word Match MeSH Name ChEBI
Tamoxifen Tamoxifen mesh:D013629 tamoxifen chebi:41774

Disease mentions

Word Match MeSH Name DOID